Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02761330 · ClinicalTrials.gov registry record · NA
Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02761330: Completed NA study, sponsored by Washington University School of Medicine.
NCT02761330 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02761330, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study is geared toward characterizing the recovery of brain activity and cognitive function following treatments of electroconvulsive therapy and ketamine general anesthesia.
Primary Outcome
A cognitive test battery was administered at 0, 30, 60, 90, and 120 minutes following return of consciousness after general anesthesia on each treatment day (1-6). The data from each treatment day (1-6) were averaged for analyses. Cognition Test Battery: * Psychomotor Vigilance Task (PVT) * Digital Symbol Substitution Task (DSST) * Motor Praxis Task (MP) * Visual Object Learning Task (VOLT) * Abstract Matching (AM) Rate of Recovery for this measure is defined as the time (in inverse hours) fo
Interventions
- DRUG Ketamine
- PROCEDURE Electroconvulsive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-09-11 |
| Phase | NA |
What the finished NCT02761330 record still lists
NCT02761330 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02761330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02761330 about?
NCT02761330 is a clinical study titled "Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia". This study is geared toward characterizing the recovery of brain activity and cognitive function following treatments of electroconvulsive therapy and ketamine general anesthesia.
What is the current status of trial NCT02761330?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2016-04. Estimated completion is 2019-09-11.
What interventions are being tested in trial NCT02761330?
The interventions under investigation include: Ketamine (DRUG), Electroconvulsive Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT02761330?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02761330's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia